Clinical Trial Update: Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on ribavirin for Hepatitis E infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis E

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Hepatitis E | Phase 4 | Status: TERMINATED